These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7453848)

  • 1. Chemotherapeutic activity and histopathologic feature of BCNU + 5-FU effect on Lewis lung carcinoma.
    Greco C; Calabresi F; Corsi A; Pericoli N; Caputo M
    Neoplasma; 1980; 27(3):279-87. PubMed ID: 7453848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lewis lung carcinoma in mice as an experimental therapy model. II. The effect of BCNU, cyclophosphamide and/or surgery treatment on early and advanced tumor in mice.
    Budzyński W
    Arch Immunol Ther Exp (Warsz); 1982; 30(5-6):373-7. PubMed ID: 7184488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Size dependence of the response of Lewis lung tumors to BCNU.
    Steel GG; Adams K; Stanley J
    Cancer Treat Rep; 1976 Dec; 60(12):1743-8. PubMed ID: 1026332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antineoplastic effect of orally administered 1-alkyl carbamoyl derivatives of 5-fluorouracil on sc implanted Lewis lung carcinoma and B16 melanoma.
    Iigo M; Hoshi A; Nakamura A; Kuretani K
    Cancer Treat Rep; 1979; 63(11-12):1895-9. PubMed ID: 118802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Animal experiments using adjuvant 5-FU and BCNU chemotherapy in stomach cancer].
    Knorr V; Schmitz R
    Chirurg; 1980 Sep; 51(9):601-5. PubMed ID: 7460686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential of the aminosterol, squalamine in combination therapy in the rat 13,762 mammary carcinoma and the murine Lewis lung carcinoma.
    Teicher BA; Williams JI; Takeuchi H; Ara G; Herbst RS; Buxton D
    Anticancer Res; 1998; 18(4A):2567-73. PubMed ID: 9703911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic activity of pretazettine on Lewis lung carcinoma.
    Furusawa E; Lockwood RH
    Proc West Pharmacol Soc; 1981; 24():45-7. PubMed ID: 7255485
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapeutic potentiation of nitrosoureas using chlorpromazine and caffeine in the treatment of murine tumors.
    Rose WC; Trader MW; Dykes DJ; Laster WR; Schabel FM
    Cancer Treat Rep; 1978 Dec; 62(12):2085-93. PubMed ID: 751716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selectivity of the antimetastatic and cytotoxic effects of 1-p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt (+/-)-1,2-di(3,5-dioxopiperazin-1-yl)propane, and cyclophosphamide in mice bearing Lewis lung carcinoma.
    Giraldi T; Sava G; Cuman R; Nisi C; Lassiani L
    Cancer Res; 1981 Jun; 41(6):2524-8. PubMed ID: 7237446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local delivery of chemotherapy and concurrent external beam radiotherapy prolongs survival in metastatic brain tumor models.
    Ewend MG; Williams JA; Tabassi K; Tyler BM; Babel KM; Anderson RC; Pinn ML; Brat DJ; Brem H
    Cancer Res; 1996 Nov; 56(22):5217-23. PubMed ID: 8912860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved treatment of a brain-tumor model. Part 2: Sequential therapy with BCNU and 5-fluorouracil.
    Gerosa MA; Dougherty DV; Wilson CB; Rosenblum ML
    J Neurosurg; 1983 Mar; 58(3):368-73. PubMed ID: 6827321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental studies on antitumor effects of lysozyme].
    Fukawa K; Nishimura N; Irino O; Nakazato K; Taguchi A; Nitta K
    Gan To Kagaku Ryoho; 1982 May; 9(5):915-23. PubMed ID: 7184434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of the chemotherapeutic effect of 5-fluorouracil by combination with guanosine 5'-monophosphate.
    Iigo M; Nakajima Y; Kuretani K; Hoshi A
    Gan; 1983 Apr; 74(2):291-8. PubMed ID: 6305753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antitumor effect of FU-O-G, new antitumor agent, following long term administration].
    Mizuno H; Inomata T; Umezawa T; Shimizu F; Arakawa M
    Gan To Kagaku Ryoho; 1984 Sep; 11(9):1848-54. PubMed ID: 6433807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and responsiveness of the Madison 109 lung carcinoma to various antitumor agents.
    Marks TA; Woodman RJ; Geran RI; Billups LH; Madison RM
    Cancer Treat Rep; 1977 Nov; 61(8):1459-70. PubMed ID: 922751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the combination of BCNU, VCR and 5-FU in the treatment of disseminated neoplasms of the large intestine].
    Luporini G; Labianca R; Fraschini P; Tedeschi L
    Minerva Med; 1980 Mar; 71(10):773-9. PubMed ID: 7360363
    [No Abstract]   [Full Text] [Related]  

  • 17. Antineoplastic activity of planar rhodium(I) complexes in mice bearing Lewis lung carcinoma and P388 leukemia.
    Sava G; Zorzet S; Mestroni G; Zassinovich G
    Anticancer Res; 1985; 5(3):249-52. PubMed ID: 4015038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor activity of calcium in combination with antitumor agents against Lewis lung carcinoma.
    Nakano K; Fujimoto S; Tokita H
    In Vivo; 1989; 3(3):147-9. PubMed ID: 2519848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological analysis of inhibition of lung metastases by fucoidan (GIV-A) prepared from brown seaweed Sargassum thunbergii.
    Itoh H; Noda H; Amano H; Ito H
    Anticancer Res; 1995; 15(5B):1937-47. PubMed ID: 8572581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of 1,19-bis(ethylamino)-5,10,15-triazanonadecane on human tumor xenografts.
    Dolan ME; Fleig MJ; Feuerstein BG; Basu HS; Luk GD; Casero RA; Marton LJ
    Cancer Res; 1994 Sep; 54(17):4698-702. PubMed ID: 8062267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.